?? Join us for the next Joint Task Force for Clinical Trial Competency (JTF) meeting!? ? The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) biannual JTF meetings are an open forum to advance clinical research workforce standards, fostering skills and knowledge that drive global impact. These virtual gatherings bring together diverse voices from across the world, and the public is warmly invited to participate.? ? ?? Date: December 10? ?? Time: 9 - 11 AM ET? ?? Location: Virtual? ? This meeting's highlights include:? Launch of a new task force focused on participant and patient partner competencies? Delphi results from the data management task force? Proposed team science competencies?? Insights from implementing the Portuguese translation of the framework? Results from the JTF competency survey in the Philippines? Training community workers using the JTF framework? ? Don't miss this opportunity to contribute to the future of clinical trial competency!? ? ?? Click here to register: https://bit.ly/3N5LhBs
Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center)
学术研究
Cambridge,Massachusetts 2,352 位关注者
Improving the integrity, safety, and rigor of global clinical trials
关于我们
The Multi-Regional Clinical Trials (MRCT) Center engages expert stakeholders from industry, academia, advocacy groups, non-profits, and regulatory agencies to take on critical issues in the conduct and oversight of clinical trials. We are a neutral convening organization associated with two of the world’s most respected names in healthcare and academia: Brigham and Women’s Hospital and Harvard University. Working in the pre-competitive space, our multidisciplinary teams collaborate to identify challenges and deliver ethical, actionable, and practical solutions for the global clinical trial enterprise, with a focus on emerging economies. Our efforts have resulted in the implementation of best practices, greater transparency, and improved safety for research participants. Our Vision: Improve the integrity, safety, and rigor of global clinical trials Our Mission: Engage diverse stakeholders to define emerging issues in global clinical trials and to create and implement ethical, actionable, and practical solutions.
- 网站
-
https://mrctcenter.org
Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center)的外部链接
- 所属行业
- 学术研究
- 规模
- 11-50 人
- 总部
- Cambridge,Massachusetts
- 类型
- 非营利机构
- 创立
- 2009
- 领域
- Multi-stakeholder engagement、Global regulatory convergence、Data transparency、Training clinical research personnel、Ethical frameworks、Clinical trials data sharing、Capacity building和Policy development
地点
-
主要
14 Story Street
4th Floor
US,Massachusetts,Cambridge,02138
Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center)员工
-
Rebecca Li
CEO, Vivli, Center for Global Data Research
-
Gloria Clare Stone
Strategic Communications and Patient Advocacy Program Development, Cross-Functional Collaboration
-
Sylvia Baedorf Kassis, MPH, CYT
Creative and thoughtful research professional with 20+ years of experience
-
Nina M. Hill, Ph.D.
President, Hill Scientific and Public Affairs, LLC; Secretariat, INTREPID Alliance; Senior Advisor, Reservoir Communications Group
动态
-
The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center is excited to share the release of an introductory video for the ICH E8(R1) Guideline – General Considerations for Clinical Studies. This video, now available on the International Council for Harmonisation (ICH) website, provides an overview of essential principles in clinical research, with a focus on quality by design.? ? Developed by the MRCT Center, this resource is designed to help researchers, sponsors, and stakeholders better understand the framework and goals of the ICH E8(R1) guideline. Stay tuned as we continue building on this foundation with a series of in-depth training modules coming soon.? ? Watch the video here: https://lnkd.in/eazxU5yh? ? #ClinicalResearch #ICHE8R1 #QualityByDesign #MRCTCenter #ICHGuidelines?
-
Barbara Bierer, Sylvia Baedorf Kassis, MPH, CYT, and Alyssa Panton from the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center), together with Devaki T. Thavarajah and Trishna Bharadia, BA(hons), MFPM(Hon), MFPM(Hon), have co-authored an insightful article, “Creating Educational Materials About Clinical Research Data for Patients and the Public: A Multifaceted Journey in the Current Digital Age,” published in Medical Writing.? ? This article builds on the MRCT Center’s ongoing commitment to advancing health and data literacy. It explores how educational resources—such as videos and infographics—can make clinical research data more accessible, addressing public concerns around data privacy, transparency, and ethical information sharing. In an age where misinformation can create barriers to understanding, these tools aim to rebuild trust and ensure that patients and the public have access to clear, understandable information.? ? https://bit.ly/48CkYwE ? #DataLiteracy #HealthLiteracy #ClinicalResearch #MRCTCenter #PatientEngagement??
-
We're excited to share a new Health Affairs article calling for a coordinated, national strategy to address longstanding gaps in the representation of underrepresented populations within U.S. clinical trials. Read the full article here: https://bit.ly/3UGqlWd Despite facing disproportionately high rates of serious health conditions, Black, Latino, Native American, Asian, and rural communities remain significantly underrepresented in clinical research. This gap not only limits scientific understanding but also restricts access to critical healthcare advancements. To close this representation gap, the Diversity Convergence Project - a collaborative effort led by Clinical Trials Transformation Initiative (CTTI), Milken Institute's FasterCures, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center), and with?contributions from the NASEM Health and Medicine Division (National Academies of Sciences, Engineering, and Medicine) – aim to close this gap by advocating for a national, cross-sector approach to improving representation in clinical trials. The project builds on the publication Toward a National Action Plan for Achieving Diversity in Clinical Trials, which outlines actionable steps across eight key areas to create a more inclusive clinical trials system. Creating lasting change requires collaboration among academia, industry, government, patient advocacy groups, and communities. Together, we can build a system where all populations have equal opportunities to contribute to and benefit from scientific advancements. Join us in making this vision a reality.
Towards A National Action Plan To Improve Representation In Clinical Trials | Health Affairs Forefront
healthaffairs.org
-
Hayat Reshid Ahmed, Program Manager at the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center), recently joined a Clinical Trial Diversity Roundtable hosted by Congresswoman Robin Kelly (IL), Chairwoman of the Congressional Black Caucus (CBC) Health Braintrust, on October 8 at La Rabida Children’s Hospital in Chicago. Congresswoman Kelly convened healthcare and research stakeholders to discuss efforts to diversify clinical trials and address the historical mistrust within the Black community, rooted in past unethical research practices.? ? The roundtable explored strategies to rebuild trust through community education and workforce diversification in the scientific and medical fields. Congresswoman Kelly heard insights from representatives of leading organizations, including the MRCT Center, Cancer Support Community, Patient-Centered Outcomes Research Institute, Genentech, Howard Brown Health-Sheridan, Bristol Myers Squibb, Walgreens Boots Alliance, City of Hope Chicago, and ATW Health Solutions. Key government partners, including the Illinois Department of Public Health, the Department of Health and Human Services, and the NIH, were also present, underscoring a united commitment to tackling these critical issues.? ? To read the MRCT Center’s remarks presented at the event, click here: https://lnkd.in/eum8wRPx? ? #ClinicalTrialDiversity #MRCTCenter #HealthEquity #CommunityTrust??
10-09-2024-Remarks-for-CBC-Chicago.pdf
mrctcenter.org
-
The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center, in collaboration with the World Health Organization (WHO), is pleased to announce the launch of Ethics and Review of Interventional Clinical Research Training, now available free of charge worldwide.? ? This course was developed to address the growing need for training on the scientific and ethical dimensions of interventional clinical trials. Tailored for research ethics committee members, chairs, administrative staff, and protocol reviewers, it also benefits regulators, investigators, study staff, and care providers involved in clinical trials.? ? Enroll today to enhance your understanding of ethical considerations in clinical research and ensure best practices in trial review.? ? https://lnkd.in/eUM4vieN? ? #ClinicalResearch #ResearchEthics #MRCTCenter #WHO #GlobalHealth? ? ?
-
Barbara Bierer, Faculty Director of the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center), has authored a viewpoint article, “Declaration of Helsinki – Revisions for the 21st Century,” published in JAMA. The article explores the significant updates in the 2024 revision of the Declaration of Helsinki, now marking its 60th anniversary.? ? The article highlights key changes, including the expansion of ethical responsibilities to all researchers, the shift from referring to “subjects” to “participants” to underscore autonomy, and the critical importance of obtaining “free and informed consent.” The article also delves into complex ethical considerations such as vulnerability, inclusivity, post-trial access, and the use of data for research—particularly in the context of multi-national clinical trials. https://bit.ly/3CetUfR #EthicsInResearch #DeclarationOfHelsinki #ClinicalResearch #MRCTCenter?
-
The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) is pleased to share an on-demand resource: ???????????????? ?????? ?????????????? ?????????? ???????????????? ??????????????????: ?????? ????????’?? ????????????????????, featuring real-world examples from the Dana-Farber Cancer Institute. This resource provides practical insights into how plain language summaries can improve transparency and communication in clinical research. Explore best practices and learn how to develop clear, accessible summaries that enhance participant understanding and engagement. Access the resource here: https://bit.ly/4hvYOR8 #PlainLanguageSummaries #PLS #PlainLanguage #PatientEngagement #MRCTCenter
-
The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) is pleased to introduce the Accessibility 101 Training Series, a six-module resource offering PowerPoint trainings on accessibility best practices for participant-facing communication. These modules are designed to help individuals and organizations improve the accessibility of patient materials, ensuring clear, inclusive communication in clinical trials. Accessible communication is essential for equitable participant engagement. Learn how to make your patient materials more effective and inclusive by exploring the series here: https://lnkd.in/gbaXH2N4 #AccessibilityinResearch #PatientCommunication #AccessibilityByDesign
-
The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) was recently featured in Brigham and Women’s Magazine, celebrating 15 years of driving ethical, actionable, and practical solutions in global clinical trials. The article highlights the MRCT Center’s leadership in: ·????????Setting global standards for clinical trials ·????????Advancing health equity and ethical practices ·????????Ensuring that clinical research benefits diverse and underserved populations Sylvia Baedorf Kassis, MPH, CYT and Willyanne DeCormier Plosky were quoted in the article, offering key takeaways on how the MRCT Center is fostering inclusivity in clinical trials and breaking down barriers for participants. Their insights underscore the importance of accessible, participant-centered research and universal design to ensure that trials are inclusive and equitable for all. https://lnkd.in/eGJsBGKA #ClinicalResearch #ResearchEthics #MRCTCenter #HealthEquity #Inclusion #15Years
Finding True North
https://magazine.brighamandwomens.org